SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-007926
Filing Date
2019-05-07
Accepted
2019-05-07 07:00:53
Documents
3
Period of Report
2019-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k050719_intecpharma.htm 8-K 28822
2 PRESS RELEASE, DATED MAY 7, 2019 f8k050719ex99-1_intec.htm EX-99.1 130407
3 GRAPHIC ex99-1_img001.jpg GRAPHIC 10149
  Complete submission text file 0001213900-19-007926.txt   174482
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 19801163
SIC: 2834 Pharmaceutical Preparations